Journal of the Society for Gynecologic Investigation
-
Publication Venue For
- Luteinizing hormone in premenopausal women may stimulate uterine leiomyomata development.. 13:130-135. 2006
- Stretching the surface epithelium.. 11:501-502. 2004
- Gene expression patterns that characterize advanced stage serous ovarian cancers.. 11:51-59. 2004
- Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.. 10:381-387. 2003
- A survey of past obstetrics and gynecology research fellows.. 9:372-378. 2002
- Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta.. 9:37-40. 2002
- Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.. 8:104-113. 2001
- Preclinical Evidence for Therapeutic Efficacy of Selective Estrogen receptor Modulators for Uterine Leiomyoma. 7:249-256. 2000
- Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats.. 7:257-265. 2000
- Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma.. 7:249-256. 2000
- Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen.. 7:S10-S15. 2000
- Central hemodynamic effects of an oxytocin receptor antagonist (atosiban) in the isolated, perfused rat heart.. 6:186-187. 1999
- Effect of cocaine on intracellular calcium regulation in myometrium from pregnant women.. 6:147-152. 1999
- Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.. 5:281-285. 1998
- Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?. 5:271-276. 1998
- Human endometrial transforming growth factor-alpha: a transmembrane, surface epithelial protein that transiently disappears during the midsecretory phase of the menstrual cycle.. 4:160-166. 1997
- Intravillous eicosanoid compartmentalization and regulation of placental blood flow.. 4:58-63. 1997
- p53lyn and p56lyn: a new signaling pathway in human endometrium and endometrial adenocarcinomas.. 4:103-109. 1997
- Correlation of serum cytokine and adhesion molecule determinations with pregnancy outcome.. 3:259-261. 1996
- Differential effects of interleukin-1 alpha, tumor necrosis factor-alpha, indomethacin, hydrocortisone, and macrophage co-culture on the proliferation of human fibroblasts and peritoneal mesothelial cells.. 2:636-642. 1995
- Pathogenesis of ovarian cancers.. 1:181-190. 1994
- Discovery of a truncted progesterone receptor (PR-M) in the mitochondria. 2006
- Identification of a novel truncated progesterone receptor (PR-M) in breast cancers and breast cancer cell lines. 2006
- Pregnancy in polycystic ovary syndrome (PPCOS) baseline characteristics: Effect of race and ethnicity on the PCOS phenotype. 2006
- Pregnancy in polycystic ovary syndrome (PPCOS): Study design and baseline characteristics of the randomized cohort. 2006
- Contribution of immune cell-derived growth factors to the pathogenesis of endometrial carcinoma. 2006
- Absence of secretory endometrium after false positive home urine luteinizing hormone testing. 2004
- Prediction of long-term versus short-term survival in advanced stage serous ovarian cancer using expression microarrays. 2004
- Selective Estrogen Receptor Modulators (SERMs): A First Step in the Development of Perfect Hormone Replacement Therapy Regimen 2000